Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Novel Schweinfurthin Analogs As Anticancer Agents

  • Read more about Novel Schweinfurthin Analogs As Anticancer Agents
Patent Cooperation Treaty
PCT/US2005/010482
Filed on 2005-03-29

Cellular and Viral Inactivation

  • Read more about Cellular and Viral Inactivation
Patent Cooperation Treaty
PCT/US2005/009559
Filed on 2005-03-22

Composite Antibodies Of Human Subgroup IV Light Chain Capable To Binding To Tag-72

  • Read more about Composite Antibodies Of Human Subgroup IV Light Chain Capable To Binding To Tag-72
US Patent 5,976,845
Filed on 1995-06-07

Composite Antibodies of Humanized Human Subgroup IV Light Chain Capable of Binding to Tag-72

  • Read more about Composite Antibodies of Humanized Human Subgroup IV Light Chain Capable of Binding to Tag-72
US Patent 7,179,899
Filed on 2002-09-25

System For Treating And Preventing Breast Cancer

  • Read more about System For Treating And Preventing Breast Cancer
US Patent 8,933,041
Filed on 2006-05-11

System for Treating and Preventing Breast Cancer

  • Read more about System for Treating and Preventing Breast Cancer
Patent Cooperation Treaty
PCT/US2004/037810
Filed on 2004-11-12

Custom Vectors For Treating And Preventing Pancreatic Cancer

  • Read more about Custom Vectors For Treating And Preventing Pancreatic Cancer
US Patent 8,901,093
Filed on 2006-05-11

Custom Vectors for Treating and Preventing Pancreatic Cancer

  • Read more about Custom Vectors for Treating and Preventing Pancreatic Cancer
Patent Cooperation Treaty
PCT/US2004/38643
Filed on 2004-11-12

Vacuolar-Type (H+)-ATPase-Inhibiting Compounds,and Uses Thereof

  • Read more about Vacuolar-Type (H+)-ATPase-Inhibiting Compounds,and Uses Thereof
US Application 12/120,778
Filed on 2008-05-15

Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection

  • Read more about Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection
Patent Cooperation Treaty
PCT/US2004/024413
Filed on 2004-07-30

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1049
  • Page 1050
  • Page 1051
  • Page 1052
  • Page 1053
  • Page 1054
  • Page 1055
  • Page 1056
  • Page 1057
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health